# Osteosarcoma in Large Breeds: Bone Amputation, Chemotherapy and Prognosis ## Key Takeaways - Osteosarcoma (OSA) is the most common primary bone tumor in large and giant breed dogs, characterized by aggressive local invasion and early metastasis, primarily to the lungs. - Key risk factors include breed predisposition (e.g., Rottweilers, Great Danes, Rhodesian Ridgebacks), larger body size, gonadectomy (spaying/neutering), and higher body condition scores. - Diagnosis involves radiographic evidence of aggressive bone lesions and chest X-rays for metastasis, with definitive confirmation via biopsy and histopathology. - The standard of care for appendicular OSA is limb amputation for local control and pain relief, invariably followed by adjuvant chemotherapy (e.g., carboplatin, doxorubicin) to target microscopic metastatic disease. - With amputation and chemotherapy, the median survival time is approximately 10-12 months, offering a good quality of life; amputation alone results in a significantly shorter survival of 4-6 months. - Early veterinary attention for persistent lameness or limb swelling in large breeds is critical for timely diagnosis, pain management, and effective treatment planning. --- Osteosarcoma (OSA) is the most common primary bone tumor in dogs, and it represents one of the most challenging diagnoses in veterinary oncology [1]. For owners of large and giant breed dogs, this diagnosis carries significant weight due to the aggressive nature of the disease and the complex treatment decisions that follow. This article provides a comprehensive, source-grounded overview of osteosarcoma in large breeds, focusing on the role of amputation, chemotherapy, and the realistic prognosis for affected dogs. **Owner Triage Summary:** If your large-breed [dog](/knowledge/veterinary-medicine/clinical-methods/dog) develops a persistent, progressive lameness or a firm swelling on a limb, especially near a joint, you should seek veterinary attention within 24 to 48 hours. Osteosarcoma is a painful and aggressive cancer that can spread to the lungs early in the disease course [2]. A veterinarian will likely recommend radiographs (X-rays) of the affected limb and chest to look for signs of a bone tumor and any evidence of metastasis. While a diagnosis of osteosarcoma is serious, treatment options such as amputation combined with chemotherapy can offer many dogs a good quality of life for a significant period. Early diagnosis is key to managing pain and planning the most effective treatment strategy [3]. ## At a Glance: Key Information for Dog Owners | Feature | Description | | :--- | :--- | | **What is it?** | A malignant (cancerous) tumor of bone, characterized by aggressive local invasion and early metastasis (spread), most often to the lungs [3]. | | **Commonly Affected** | Large and giant breed dogs, such as Rottweilers, Great Danes, and Rhodesian Ridgebacks [4]. | | **Typical Age** | Middle-aged to older dogs, with a median age of 7-8 years, though it can occur in younger dogs [1]. | | **Most Common Sites** | The metaphysis (wide end) of long bones: distal radius (just above the wrist), proximal humerus (shoulder), distal femur (stifle), and proximal tibia (stifle) [5]. | | **Primary Treatment** | Limb amputation or limb-sparing surgery, almost always followed by adjuvant chemotherapy [6][1]. | | **Role of Chemotherapy** | To delay or prevent the growth of microscopic metastases (secondary tumors) that are often present but undetectable at the time of diagnosis [7][2]. | | **Prognosis** | With amputation and chemotherapy, many dogs survive 10-12 months, though some can live much longer. Without chemotherapy, survival is typically shorter, around 4-6 months [8][1]. | | **Main Goal of Treatment** | To alleviate pain and provide a good quality of life for as long as possible. | ## Understanding Osteosarcoma: The Biology of the Disease Osteosarcoma is a tumor that arises from mesenchymal cells, the cells that normally form bone and cartilage [9]. In dogs, it is a highly aggressive cancer. The tumor itself causes significant local destruction of bone, leading to pain and a high risk of pathological fractures. However, the most life-threatening aspect of OSA is its strong tendency to metastasize, or spread, to other parts of the body, most commonly the lungs [8][1]. At the time of initial diagnosis, it is estimated that the vast majority of dogs already have microscopic, undetectable cancer cells in their lungs [2]. This is why a local treatment like amputation alone is rarely curative; the microscopic disease will eventually grow into visible, fatal metastases. ### The Appendicular Skeleton: The Primary Site In dogs, OSA most frequently affects the appendicular skeleton, which includes the bones of the limbs [10][1]. The most common predilection sites are the metaphyses of long bones, specifically the distal radius (forelimb, just above the carpus), proximal humerus (forelimb, at the shoulder), distal femur (hindlimb, just above the stifle), and proximal tibia (hindlimb, just below the stifle) [5]. Forelimb tumors are reported more frequently than hindlimb tumors [11]. While less common, OSA can also occur in the axial skeleton (skull, spine, ribs) and, very rarely, in soft tissues (extraskeletal OSA) [10][9]. ## Causes and Risk Factors: Why Large Breeds? The exact cause of osteosarcoma is not fully understood, but it is believed to be a complex interaction of genetic, physical, and potentially environmental factors. Several key risk factors have been identified through epidemiological studies. ### Breed and Genetics Breed is a major risk factor, with large and giant breeds being overwhelmingly predisposed [1]. A large UK case-control study identified several breeds with significantly increased odds of developing OSA. The Rottweiler and Great Dane had more than 10 times the odds of developing the disease compared to crossbred dogs. Notably, the Rhodesian Ridgeback was also identified as a high-risk breed, with an odds ratio of 11.31 [4]. These findings are supported by other studies, which consistently show Rottweilers and Great Danes to be at increased risk [12]. Genome-wide association studies have begun to uncover the genetic basis for this predisposition. A study in Leonberger dogs, another giant breed with a high risk of OSA, found a significant association with the CDKN2A/B gene locus on canine chromosome 11 [13]. This same locus has been implicated in OSA risk in other breeds, such as the Greyhound [13]. The disease has a complex genetic basis with moderate heritability, meaning that a dog's genetic makeup plays a significant role in its likelihood of developing cancer [13][14]. ### Body Size, Conformation, and Other Factors Larger body mass and longer bone length have been historically associated with increased OSA risk [4]. While the exact mechanism is unclear, it may relate to the higher number of cell divisions in the growth plates of larger dogs, which increases the chance of a cancer-causing mutation. Other risk factors identified in a Canadian study include: - **Gonadectomy:** Neutered or spayed dogs had increased odds of developing appendicular OSA compared to intact dogs. Interestingly, spayed females appeared to have the greatest risk [12]. - **Body Condition Score (BCS):** A higher BCS, indicating obesity or being overweight, was independently associated with an increased risk of OSA [12]. - **History of Lameness:** Dogs with a previous history of lameness conditions (other than OSA) had increased odds of being diagnosed with the tumor [12]. ### Age and Sex OSA is typically a disease of middle-aged to older dogs, with a median age of 7-8 years [1]. While it can occur in younger dogs, it is less common. Some studies have shown a higher proportion of cases in females, though this is not a consistent finding across all research [11]. ## Clinical Presentation: Signs and Symptoms The most common clinical sign of appendicular osteosarcoma is a progressive, often subtle, lameness in one limb. This lameness may initially be intermittent and may temporarily improve with rest or anti-inflammatory medications, which can delay diagnosis [3]. As the tumor grows, it causes increasing pain. Other signs owners may notice include: - **Swelling:** A firm, sometimes warm swelling may be palpable at the tumor site. This is often most noticeable around joints like the wrist or shoulder [3]. - **Pain:** The dog may show signs of pain when the area is touched or manipulated. - **Weight Loss:** A general loss of condition can occur as the disease progresses [3]. - **Lethargy and Reduced Appetite:** These are non-specific signs that can accompany the pain and systemic effects of cancer. - **Pathological Fracture:** The tumor weakens the bone, making it susceptible to breaking with minimal trauma. This can cause a sudden, severe, non-weight-bearing lameness. ## Veterinary Examination and Diagnostic Workup If your veterinarian suspects osteosarcoma, they will follow a systematic diagnostic approach. This is critical not only to confirm the diagnosis but also to stage the disease and determine the best treatment plan. ### 1. Physical and Orthopedic Examination The veterinarian will perform a thorough physical exam and a detailed orthopedic and neurological examination to assess the lameness, identify the source of pain, and rule out other causes such as ligament injuries or arthritis. ### 2. Diagnostic Imaging - **Radiographs (X-rays):** This is the first-line imaging test. X-rays of the affected limb will typically show an aggressive bone lesion with a mixed pattern of bone destruction (lysis) and new bone production (proliferation) [3]. The margins of the lesion are often indistinct. Thoracic (chest) radiographs are essential to check for visible pulmonary metastases. However, it is important to note that many dogs have no visible metastases on X-rays at the time of diagnosis, despite having microscopic disease [3][2]. - **Advanced Imaging:** In some cases, computed tomography (CT) or magnetic resonance imaging (MRI) may be recommended. CT is more sensitive than radiographs for detecting pulmonary metastases and can better define the extent of the bone tumor for surgical planning [10]. ### 3. Definitive Diagnosis: Biopsy and Histopathology While imaging findings can be highly suggestive of OSA, a definitive diagnosis requires a biopsy. A sample of the tumor is obtained and examined by a veterinary pathologist under a microscope. The histopathology report will confirm the presence of osteosarcoma and may describe the specific subtype (e.g., chondroblastic, osteoblastic) and the tumor's grade, which can provide some prognostic information [10]. The biopsy procedure is usually performed under sedation or anesthesia with imaging guidance. ### 4. Staging and Biomarkers Staging is the process of determining how far the cancer has spread. This includes the thoracic imaging described above. In some cases, a bone scan or CT scan of the whole body may be recommended to check for metastases in other bones or organs. Researchers are also investigating molecular markers, such as the expression of the P16 tumor suppressor gene, to better predict outcomes and tailor treatment, though these are not yet standard clinical tests [2]. ## Evidence-Based Management: Amputation and Chemotherapy The standard of care for appendicular [osteosarcoma in dogs](/knowledge/veterinary-medicine/clinical-methods/osteosarcoma-in-dogs) is aggressive local control combined with systemic chemotherapy. The goal is twofold: to eliminate the painful primary tumor and to treat the microscopic metastatic disease that is almost certainly present [6][1]. ### Limb Amputation: The Gold Standard for Local Control Limb amputation is the most common and effective method for controlling the primary tumor [6][1]. It is a major surgery that removes the entire affected limb. - **Why Amputation?** The primary purpose of amputation is to provide immediate, permanent relief from the severe pain caused by the bone tumor. It eliminates the risk of a painful pathological fracture at the tumor site. Most dogs, especially those that are otherwise healthy, adapt remarkably well to life on three legs. Amputation is generally well-tolerated, and most dogs regain excellent mobility and quality of life. - **The Procedure:** The surgery involves removing the entire limb, either through the shoulder joint (forelimb) or hip joint (hindlimb), or by removing the entire limb bone. For proximal humerus tumors, a more extensive surgery called a scapulectomy (removal of the shoulder blade) may be required [3]. - **Post-Operative Recovery:** Most dogs are hospitalized for 1-2 days after surgery. Pain management is a critical part of the recovery process. Owners need to be prepared to help their dog with activities like going outside and navigating stairs during the initial recovery period, which typically lasts 2-4 weeks. ### Limb-Sparing Surgery: An Alternative For a small subset of dogs, limb-sparing surgery may be an option. This procedure aims to remove the tumor while preserving the limb. It is typically only considered for tumors in the distal radius (wrist area) that are small and have not broken through the bone cortex [5]. The procedure is complex and carries a higher risk of complications, such as infection and implant failure, compared to amputation [5]. One described technique involves using a vascularised ulnar transposition autograft, where a section of the ulna bone with its blood supply is moved to replace the cancerous section of the radius [5]. While this can be successful, amputation remains the more common and reliable choice for local control. ### Chemotherapy: Addressing the Systemic Disease Chemotherapy is an essential component of the treatment plan. It is termed "adjuvant" chemotherapy because it is given after surgery to target and destroy the microscopic cancer cells that have already spread to other parts of the body, primarily the lungs [7][6]. - **Standard Protocols:** The most commonly used chemotherapy drugs for canine OSA are **carboplatin** and **doxorubicin** [8][6]. These are often used as single agents or in combination protocols. Treatment typically consists of a series of intravenous infusions given every 2-3 weeks for a total of 4-6 doses. - **Effectiveness:** Adjuvant chemotherapy has been shown to significantly prolong survival times in dogs with appendicular OSA [7]. While amputation alone can provide a median survival time of around 4-5 months, the addition of chemotherapy extends this to a median of 10-12 months or longer [8][1]. A recent study in small-breed dogs found that those receiving adjuvant chemotherapy after amputation had a significantly longer median survival time (353 days) compared to those that underwent surgery alone (150 days) [7]. This confirms the importance of chemotherapy in managing the metastatic spread of this disease. - **Side Effects:** Chemotherapy in dogs is generally better tolerated than in humans. Side effects are usually mild and manageable, and may include temporary lethargy, decreased appetite, vomiting, or diarrhea. These are typically short-lived and can be managed with supportive medications. The risk of severe side effects is relatively low. ### Emerging and Alternative Therapies Research is ongoing to find better treatments for osteosarcoma. Several studies are exploring new targeted therapies and drug combinations. - **Proteasome Inhibitors:** Pre-clinical studies have shown that drugs like bortezomib can potently induce cell death (apoptosis) in canine osteosarcoma cells. Combining these drugs with doxorubicin or carboplatin showed increased toxicity to cancer cells compared to either drug alone [8]. - **Molecularly Targeted Agents:** A recent study screened 12 targeted anticancer drugs against canine and human OSA cell lines. It identified four drugs (alisertib, crizotinib, onvansertib, and sorafenib) that showed significant responses at clinically relevant exposures [15]. - **Metastasectomy and Ablation:** For dogs that develop a limited number of pulmonary metastases, surgical removal (metastasectomy) may be an option. More recently, a minimally invasive technique called percutaneous microwave ablation (MWA) has been described as a potential treatment for solitary lung metastases [16]. These options are not considered standard care and depend on the individual case. ## Prognosis: What to Expect The prognosis for a dog diagnosed with osteosarcoma is guarded but not hopeless. It is a serious cancer, and the majority of dogs will eventually succumb to the disease, even with aggressive treatment [2]. However, the goal of treatment is to provide a good quality of life for as long as possible. - **With Amputation and Chemotherapy:** The current standard of care provides a median survival time of approximately 10-12 months [8][1]. This means that half of all dogs treated will live longer than this. A significant percentage of dogs, perhaps 20-30%, will live for two years or more. These dogs can enjoy an excellent quality of life, free from bone pain. - **With Amputation Alone:** If chemotherapy is declined, the median survival time drops significantly to around 4-6 months, as the microscopic metastases will inevitably grow into fatal lung tumors [8][1]. - **Without Surgery:** For dogs that do not undergo amputation, the primary tumor continues to cause severe pain, and the risk of a pathological fracture is high. Palliative treatments, such as radiation therapy, can help manage pain but do not address the underlying tumor or the metastatic disease. Survival in these cases is typically short, often less than 3 months. **Prognostic Factors:** Several factors can influence an individual dog's prognosis. These include the tumor's histologic grade, the presence of metastases at diagnosis, and the dog's overall health. Researchers are actively looking for biomarkers, like P16 expression, that can help predict which dogs are most likely to respond well to chemotherapy, but these are not yet part of standard clinical care [2]. ## Unsafe Home Remedies and What to Avoid When a dog is diagnosed with osteosarcoma, owners may be tempted to try home remedies. Some of these can be harmful and should be avoided. - **Human Pain Medications:** Never give a dog human pain relievers like ibuprofen, naproxen, or acetaminophen. These can be highly toxic and even fatal to dogs. - **Unproven Supplements:** There are many unregulated supplements marketed for cancer in pets. These are not proven to be effective and can sometimes interfere with conventional treatments. Always discuss any supplement with your veterinary oncologist before giving it to your dog. - **Delaying Surgery:** Some owners may delay amputation hoping for a less invasive option. This can be detrimental, as the tumor will continue to grow and cause severe pain, and the risk of a fracture increases. ## Prevention and Early Detection There is no known way to completely prevent osteosarcoma. However, understanding the risk factors can help with early detection. For high-risk breeds like Rottweilers, Great Danes, and Rhodesian Ridgebacks, owners should be vigilant about any lameness or swelling [4][12]. Regular veterinary check-ups are important, especially for middle-aged to older large-breed dogs. Maintaining a healthy body weight may help reduce the risk, as obesity has been identified as an independent risk factor [12]. The decision to neuter or spay a dog should be made in consultation with a veterinarian, as the research suggests a potential link between gonadectomy and an increased risk of OSA [12]. ## Limitations and When to Contact a Veterinarian This article provides a comprehensive overview based on current scientific literature. However, it is crucial to understand its limitations. Breed-level information cannot predict what will happen to your individual dog. Each case of osteosarcoma is unique, and the clinical behavior, response to treatment, and overall prognosis can vary significantly. The information here is not a substitute for professional veterinary advice. You should contact your veterinarian or a board-certified veterinary oncologist immediately if your dog shows any of the following signs: - **Persistent lameness** lasting for more than a few days. - **A firm, painful swelling** on a limb, especially near a joint. - **Sudden, severe lameness** that could indicate a bone fracture. - **Difficulty getting up, lying down, or climbing stairs.** - **A noticeable decrease in appetite or energy levels.** Early intervention is critical for managing pain and giving your dog the best possible chance at a good outcome. ## Frequently Asked Questions ### What is the life expectancy of a large breed dog with osteosarcoma? With the standard treatment of amputation followed by chemotherapy, the median survival time is approximately 10 to 12 months. This means many dogs live a year or more, and some can live for several years with a good quality of life. ### Can a dog live a good life after a leg amputation? Yes, absolutely. Most dogs, especially those that are otherwise healthy, adapt very well to life on three legs. Amputation removes the source of severe bone pain, and after a recovery period of a few weeks, most dogs are able to run, play, and enjoy a good quality of life. ### Is chemotherapy necessary after amputation for osteosarcoma? Yes, it is strongly recommended. Amputation alone treats the primary tumor but not the microscopic cancer cells that have likely already spread to the lungs. Adjuvant chemotherapy is essential to delay or prevent the growth of these metastases and significantly prolongs survival time. ### What is the survival time for a dog with osteosarcoma without treatment? Without any treatment, the prognosis is very poor. The primary tumor causes severe pain and the risk of a fracture is high. Survival is typically short, often only 1 to 3 months after diagnosis. ### What are the most common breeds to get osteosarcoma? Large and giant breed dogs are most commonly affected. Breeds with a significantly higher risk include the Rottweiler, Great Dane, and Rhodesian Ridgeback. Other large breeds like Leonbergers and Greyhounds are also at increased risk. ### What does osteosarcoma look like on an X-ray? On radiographs, osteosarcoma typically appears as an aggressive, destructive bone lesion. It often shows a mixed pattern of bone lysis (destruction) and new bone production (proliferation), with poorly defined margins. The appearance is highly suggestive of a malignant bone tumor. ### What are the first signs of bone cancer in dogs? The most common first sign is a progressive, sometimes intermittent, lameness in one limb. You may also notice a firm swelling on the leg, especially near a joint like the wrist or shoulder. The dog may also show signs of pain when the area is touched. ### Are there alternative treatments to amputation for osteosarcoma? Yes, limb-sparing surgery is an option for a small number of dogs with tumors in the distal radius that meet specific criteria. However, it is a complex procedure with more complications than amputation. Palliative treatments like radiation therapy can help manage pain but do not cure the disease. **This article is educational and is not a substitute for veterinary diagnosis or treatment.** ## Sources [1] [Biology, diagnosis and treatment of canine appendicular osteosarcoma: similarities and differences with human osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/20889358/) [2] [Evaluation of P16 expression in canine appendicular osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/28633676/) [3] [A Case Report of Proximal Radioulnar Osteosarcoma in a Great Dane Dog.](https://pubmed.ncbi.nlm.nih.gov/42428697/) [4] [Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control study.](https://pubmed.ncbi.nlm.nih.gov/33750475/) [5] [Ipsilateral vascularised ulnar transposition autograft for limb-sparing surgery of the distal radius in 2 dogs with osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/17137057/) [6] [Expression profiling in canine osteosarcoma: identification of biomarkers and pathways associated with outcome.](https://pubmed.ncbi.nlm.nih.gov/20860831/) [7] [Adjuvant Chemotherapy Is Associated With Prolonged Survival Time in Small-Breed Dogs Undergoing Amputation for Appendicular Osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/39797571/) [8] [Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/29998615/) [9] [Primary omentum extraskeletal osteosarcoma in a dog: case report.](https://pubmed.ncbi.nlm.nih.gov/37859868/) [10] [Aggressive chondroblastic osteosarcoma in a dog: A case report.](https://pubmed.ncbi.nlm.nih.gov/32206233/) [11] [Casuistry of oncological diseases in dogs, focusing on bone tumors treated at the Veterinary Hospital of the University of the Republic, Uruguay (2018-2023).](https://pubmed.ncbi.nlm.nih.gov/41695823/) [12] [Risk factors for appendicular osteosarcoma occurrence in large and giant breed dogs in western Canada.](https://pubmed.ncbi.nlm.nih.gov/36733647/) [13] [Genome-Wide Analyses for Osteosarcoma in Leonberger Dogs Reveal the CDKN2A/B Gene Locus as a Major Risk Locus.](https://pubmed.ncbi.nlm.nih.gov/34946912/) [14] [Risk-modeling of dog osteosarcoma genome scans shows individuals with Mendelian-level polygenic risk are common.](https://pubmed.ncbi.nlm.nih.gov/30890123/) [15] [Comparative Response of Canine and Human Osteosarcoma Tumour Cell Lines to Molecularly Targeted Anticancer Agents at Clinically Relevant Exposures With Analysis of Genomic Biomarkers.](https://pubmed.ncbi.nlm.nih.gov/42036120/) [16] [Percutaneous microwave ablation of solitary presumptive pulmonary metastases in two dogs with appendicular osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/32521058/) [17] [Single-Nuclei Multiome (ATAC + Gene Expression) Sequencing of a Primary Canine Osteosarcoma Elucidates Intra-Tumoral Heterogeneity and Characterizes the Tumor Microenvironment.](https://pubmed.ncbi.nlm.nih.gov/38003552/) [18] [Comparative Transcriptome Analysis Quantifies Immune Cell Transcript Levels, Metastatic Progression, and Survival in Osteosarcoma.](https://pubmed.ncbi.nlm.nih.gov/29066513/) [19] [Osteosarcoma in Baboons (Papio spp).](https://pubmed.ncbi.nlm.nih.gov/25926401/) [20] [The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.](https://pubmed.ncbi.nlm.nih.gov/25890299/) ## Related Clinical & Scientific Guides * [Lymphoma in Cats: High-Grade vs Low-Grade GI Alimentary Lymphoma](/knowledge/veterinary-medicine/dermatology-oncology/lymphoma-in-cats-high-grade-vs-low-grade-gi-alimentary-lymphoma 2) * [Lymphoma in Cats: High-Grade vs Low-Grade GI Alimentary Lymphoma](/knowledge/veterinary-medicine/dermatology-oncology/lymphoma-in-cats-high-grade-vs-low-grade-gi-alimentary-lymphoma) * [Symmetrical Lupoid Onychodystrophy SLO: Nails Sloughing and Omega-3 Dose](/knowledge/veterinary-medicine/dermatology-oncology/symmetrical-lupoid-onychodystrophy-slo-nails-sloughing-and-omega-3-dose)